Avant Research Associates, LLC - Austin

Austin, Texas 78704

We've found

3 trials

at this facility

Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Austin, TX

A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Austin, TX

An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Austin, TX

Use our guide to learn which trials are right for you!